Patient Intake At the 'MOvement and REhabilitation (MO.RE.)

NCT06858241 | Completed

• 1 other identifier: 299/2024/OSS/AUSLRE
• Study Type: observational
• Target: 95
• Locations: 1 country
• Sites: 1

Brief Summary

In recent years, there has been an exponential increase in studies regarding the benefits of physical activity in oncology, with significant results on improving both physical and psychological outcomes. When appropriately dosed, physical activity can help individuals with a history of cancer to cope with pain and Cancer-Related Fatigue, and improve their quality of life, both during and after cancer treatments. Given the incidence and prevalence of cancer, along with the increase in survival due to advancements in cancer care, it is becoming increasingly important to promote an active lifestyle. For this reason, in August 2022, the MOvement and REhabilitation (MO.RE.) clinic was opened by the S.C. of MFR, dedicated to individuals with a history of cancer at any stage of treatment, with the aim of offering consultations with an experienced physiotherapist to personalize a physical activity program that can help regain a good quality of life, return to daily activities, and prevent the onset of other diseases and recurrences. The clinic also provides therapeutic education activities, following WHO guidelines, on proper lifestyle for wellness and secondary prevention. The aim of our study is to retrospectively analyze the patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024, in order to describe and evaluate the appropriateness of access to the clinic, the expressed needs, and some clinical and rehabilitative data."

Conditions

Oncologic Complications

Keywords

Onc-hematological patients; Physical Activity; Physical Exercise

Outcome Measures

Primary Outcomes (1)

• Number of cancer patients who accessed the MO.RE. service, matching appropriateness criteria

  The referral of the patient is considered appropriate, if the patient corresponds to these criteria: * cancer patient needing information about a personalized physical activity program * patient with a good performance status evaluated according to ECOG performance status scale (score 0 or 1) * absence of bone metastases.

  2 years

Secondary Outcomes (5)

• Sample description by socio-demographic data

  2 years

• Sample description by clinical data

  2 years

• Number of cancer patients who needed counselling on physical activity and self-managed exercise after MO.RE. access

  2 years

• Number of cancer patients who needed counselling on physical activity and self-managed exercise after MO.RE. access

  2 years

• Number of cancer patients who needed a physiatrist evaluation before exercise

  2 years

Study Arms (1)

Patients who requested a consultation at the MO.RE. clinic between August 2022 and June 2024

Patients with a history of malignant tumor diagnosis, managed by the Oncology and Hematology Units that need a MO.RE. clinic consultation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with a history of malignant tumor diagnosis, managed by the Oncology and Hematology Units of the USL-IRCCS of Reggio Emilia, who requested a consultation at the MO.RE. clinic between August 2022 and June 2024

You may qualify if:

• Diagnosis of malignant tumor
• Access to the MO.RE. clinic for recommendations on exercise/physical activity
• Age over 18 years

You may not qualify if:

• Language barrier
• Conditions that prevent the individual from performing physical activity independently

Sponsors & Collaborators

• Azienda USL Reggio Emilia - IRCCS: lead

Study Sites (1)

AUSL-IRCCS of Reggio EmiliaOperational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia, Reggio Emilia, Emilia Romagna 42123

Reggio Emilia, 42123, Italy

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

• Stefania Fugazzaro, MD

  AUSL-IRCCS of Reggio Emilia

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 4, 2025
• First Posted: March 5, 2025
• Study Start: August 1, 2022
• Primary Completion: June 30, 2024
• Study Completion: June 30, 2024
• Last Updated: March 5, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

IT (1)